Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Biotechnology Cancer Cures -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (75)	6/22/1999 10:39:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 226

Yeah, I knew it wasn't me. It wasn't, was it? - g - Coffee!! Peter, Where'd..... amazing communication skills. A blanket "thanks".

To: Biomaven who wrote (75)	6/23/1999 6:44:00 AM
From: SnowShredder	Read Replies (1) \| Respond to of 226

Hi Peter, Thanks a ton. I'll be sure to keep an eye on SYBB. I really think the Reovirus Therapy will work great. The only downside I can see (about this project @ this time) is that some pathogenic disease will be discovered to be caused by it...due to the increased exposure, and that I think they are using a wt virus...so I'm not sure about the patent situation. I'll definitely will have to learn more about it & SYBB, but I think I have plenty of time since it will be years before trials are done. The tumor specificity? is the most appealing characteristic <imo>. I'm wondering if SYBB will have enough $$$ to do this on it's own...considering trials are just starting. Best of Luck, Where'd He Go?